Screening: Interactive map of lung cancer screening (European Union)

From Beacon
Revision as of 13:47, 19 August 2024 by Francine (talk | contribs) (Created page with "{{forproviders}} {{forpolicymakers}} Go back to European Union page '''Primary purpose:''' To provide a comprehensive, up-to-date visualisation of global clinical trials, implementation studies, and organized LDCT screening programs, enhancing research accessibility and comparability. '''Sponsor, manager or home institution:''' dataOwner::Lung Cancer Policy Network. '''Type of information:''' Detailed entries about ongoing and completed clinical trials, implem...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Go back to European Union page

Primary purpose: To provide a comprehensive, up-to-date visualisation of global clinical trials, implementation studies, and organized LDCT screening programs, enhancing research accessibility and comparability.

Sponsor, manager or home institution: Lung Cancer Policy Network.

Type of information: Detailed entries about ongoing and completed clinical trials, implementation studies, and national or regional organized LDCT screening programs. The map also offers features for comparing these records and a user guide to help maximize its use, ensuring users can access and understand a wide array of lung cancer screening initiatives globally. screening. Click here to learn more.

Data level: global level.

Cancer areas of interest: C30-C39: Lung/chest cancers. Click here to learn more.

Access to information: Click here to access.